Original filing (PDF)20250108220208NAL0011695665022

Ziada Therapeutics

Name: Ziada Therapeutics — Ziada Therapeutics 401(k) Plan, Form 5500 (2024)
Creator: Ziada Therapeutics
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Ziada Therapeutics 401(k) Plan

401(k) retirement plan · Ziada Therapeutics' Ziada Therapeutics 401(k) Plan filed a Form 5500 for plan year 2024.

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

QIAN LIU signed Ziada Therapeutics' 2024 Form 5500 as plan administrator.

QIAN LIU — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Ziada Therapeutics' EIN is 93-2673251.

EIN 93-2673251

Plan number 001

Plan year 2024

ACK ID 20250108220208NAL0011695665022

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for Ziada Therapeutics from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

Ziada Therapeutics' plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ZIADA THERAPEUTICS.

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Helping the score